13237941 · Active · incorporated 5 years, 7 months ago · Oxford
Biotech Biotech & Life Sciences Drug Discovery Series B+
MitoRx Therapeutics develops first-in-class mitochondrial protective therapies for conditions like obesity and cardiometabolic diseases.
https://www.mitorxtherapeutics.com/
Mitorx Therapeutics Limited is a private limited company registered at Companies House under number 13237941, incorporated on 2 March 2021, with a registered office in Oxford. Its current status on the register is active. Its filed nature of business covers research and experimental development on biotechnology (SIC 72110) and other business support service activities n.e.c. (SIC 82990). Sonde has indexed 78 filings for this company, including 6 funding rounds. Its most recent round closed in September 2026, raising £250k.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 6 | Sep 2026 | £250k | £1.90 |
| Round 5 | Dec 2025 | £7.3m | £1.90 |
| Round 4 | Dec 2024 | £827k | £1.24 |
| Round 3 | Jun 2024 | £1.9m | £1.24 |
| Round 2 | Mar 2023 | £1.9m | £1.24 |
| Round 1 | Mar 2022 | £1.6m | £75.00 |
Showing the 13 most recent of 78 filings.
See the complete cap table with every shareholder, founder tags, dilution across 34 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.